Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The market for these therapies is on the brink of major expansion, with projections suggesting that the number of GLP-1 patients worldwide will more than double between 2025 and 2029
& Boland, C
Important Medication Info: FDA-approved medications such as Saxenda, Victoza, Wegovy, and Ozempic are proprietary to Novo Nordisk, while Mounjaro and Zepbound are products of Eli Lilly and Company
Once Retatrutide is licensed, pharmacies like ours may be able to offer consultations and private treatment options
:max_bytes(150000):strip_icc()/HowDoesOzempicWork-7e49ed58c8f94ab88adb9dc10e5b7ba6.jpg)
High Cost of GLP-1 Targeted Peptide Drugs The high cost of GLP-1 targeted peptide drugs is a significant barrier to widespread adoption, especially in low- and middle-income countries
US$ 20.37
US$ 23.43
US$ 25.15
US$ 24.13
US$ 29.33
US$ 20.22
US$ 21.81
US$ 21.55
US$ 23.33
